Celcuity Inc. (CELC) Insider Trading Activity

NASDAQ$105.63
Market Cap
$4.89B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
50 of 827
Rank in Industry
40 of 469

CELC Insider Trading Activity

CELC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$9,571,319
1
20
Sells
$6,803,590
4
80

Related Transactions

BAKER BROS. ADVISORS LP10 percent owner
1
$9.57M
0
$0
$9.57M
Buller Richard Edirector
0
$0
2
$485,203
$-485,203
Dalvey Daviddirector
0
$0
2
$6.32M
$-6.32M

About Celcuity Inc.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Insider Activity of Celcuity Inc.

Over the last 12 months, insiders at Celcuity Inc. have bought $9.57M and sold $6.8M worth of Celcuity Inc. stock.

On average, over the past 5 years, insiders at Celcuity Inc. have bought $3.76M and sold $1.45M worth of stock each year.

Highest buying activity among insiders over the last 12 months: BAKER BROS. ADVISORS LP (10 percent owner) — $9.57M.

The last purchase of 170,100 shares for transaction amount of $9.57M was made by BAKER BROS. ADVISORS LP (10 percent owner) on 2025‑09‑08.

List of Insider Buy and Sell Transactions, Celcuity Inc.

2025-12-01SaleBuller Richard Edirector
1,100
0.0024%
$98.13
$107,948
+2.25%
2025-11-21SaleDalvey Daviddirector
15,000
0.0332%
$100.00
$1.5M
+5.66%
2025-11-20SaleBuller Richard Edirector
3,900
0.0087%
$96.73
$377,255
+3.25%
2025-09-08PurchaseBAKER BROS. ADVISORS LP10 percent owner
170,100
0.3608%
$56.27
$9.57M
+12.86%
2025-07-28SaleDalvey Daviddirector
109,325
0.3459%
$44.07
$4.82M
+47.02%
2024-10-23SaleBuller Richard Edirector
350
0.0009%
$16.25
$5,688
-19.60%
2024-08-23SaleBuller Richard Edirector
350
0.0009%
$16.95
$5,933
-26.74%
2024-06-21SaleBuller Richard Edirector
350
0.0011%
$15.68
$5,488
-19.65%
2024-04-24SaleBuller Richard Edirector
350
0.0011%
$17.06
$5,971
-13.43%
2024-02-21SaleBuller Richard Edirector
350
0.0014%
$14.15
$4,953
+9.41%
2023-12-20SaleBuller Richard Edirector
350
0.0015%
$14.37
$5,030
+9.12%
2023-12-15SaleDalvey Daviddirector
2,940
0.0121%
$14.57
$42,847
+6.71%
2023-12-14SaleDalvey Daviddirector
5,000
0.0206%
$14.75
$73,752
+6.35%
2023-12-13SaleDalvey Daviddirector
5,000
0.0202%
$14.50
$72,500
+6.32%
2023-12-12SaleDalvey Daviddirector
2,060
0.0085%
$14.61
$30,089
+9.27%
2023-12-08SaleDalvey Daviddirector
5,000
0.0207%
$15.00
$75,000
+6.50%
2023-12-07SaleDalvey Daviddirector
5,000
0.0207%
$14.85
$74,250
+6.14%
2023-10-25SaleBuller Richard Edirector
350
0.0016%
$10.23
$3,581
+55.32%
2023-08-30SaleBuller Richard Edirector
350
0.0015%
$9.28
$3,248
+58.21%
2023-08-23SaleBuller Richard Edirector
300
0.0013%
$9.82
$2,946
+46.64%
Total: 47
*Gray background shows transactions not older than one year

Insider Historical Profitability

16.77%
BAKER BROS. ADVISORS LP10 percent owner
7211484
15.5855%
$761.75M10
Dalvey Daviddirector
110000
0.2377%
$11.62M08
Buller Richard Edirector
7260
0.0157%
$766,873.80028
Sullivan Brian F.Chief Executive Officer
3016643
6.5196%
$318.65M10
+9.33%
NIGON RICHARDdirector
96032
0.2075%
$10.14M70
+17.87%
Furcht Leodirector
10250
0.0222%
$1.08M10
+22.55%
Murphy Polly A.director
5000
0.0108%
$528,150.0010
+10.68%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$52,263,649
70
1.18%
$4.72B
$18,659,984
32
-10.07%
$5.59B
$1,275,975,557
32
19.44%
$4.64B
$103,944,213
17
5.95%
$6.98B
$74,605,681
14
47.06%
$4.98B
$177,517,505
13
16.65%
$4.49B
$75,296,863
13
33.79%
$4.79B
$57,686,748
13
21.11%
$6.2B
$9,976,473
12
29.52%
$5.24B
$91,269,919
12
12.86%
$4.43B
$2,477,801
11
4.98%
$4.87B
$35,908,794
10
126.31%
$5.6B
Celcuity Inc.
(CELC)
$3,073,199
10
16.77%
$4.89B
$11,898,979
10
54.58%
$6.79B
$1,711,150
9
31.59%
$4.36B
$25,064,843
9
12.75%
$4.59B
$20,499,451
9
71.54%
$5.52B
$2,246,813
6
70.15%
$4.88B
$41,376,000
4
-12.07%
$6.08B

CELC Institutional Investors: Active Positions

Increased Positions138+140.82%18M+55.79%
Decreased Positions47-47.96%10M-32.07%
New Positions93New8MNew
Sold Out Positions14Sold Out2MSold Out
Total Postitions189+92.86%39M+23.72%

CELC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Baker Bros. Advisors Lp$800,603.0017.21%7.92M+2M+45.23%2025-09-30
Perceptive Advisors Llc$299,002.006.43%2.96M+1M+81.01%2025-09-30
Blackrock, Inc.$227,206.004.88%2.25M+175,764+8.49%2025-09-30
Nea Management Company, Llc$216,871.004.66%2.14M-150,000-6.54%2025-09-30
Vanguard Group Inc$208,252.004.48%2.06M+391,262+23.46%2025-09-30
Morgan Stanley$153,010.003.29%1.51M+728,773+92.95%2025-09-30
Soleus Capital Management, L.P.$119,230.002.56%1.18M-2M-60.86%2025-09-30
Tang Capital Management Llc$116,311.002.5%1.15M+1MNew2025-09-30
Eventide Asset Management, Llc$110,121.002.37%1.09M-300,628-21.64%2025-09-30
Ubs Group Ag$86,422.001.86%854,483+769,891+910.12%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.